Glooko

By Laura Lovett 01:45 pm June 4, 2019
On Friday the American Diabetes Association is set to kick of its annual scientific session in San Francisco. Diabetes focused organizations have already begun to make announcements ahead of the show. MobiHealthNews compiled a roundup of the diabetes-related news coming out this week.    GLOOKO, T1D TEAM UP This morning, diabetes management platform Glooko announced that it is teaming up with...
By Laura Lovett 11:16 am May 23, 2019
Two months after stepping down from his role as the FDA Commissioner, Dr. Scott Gottlieb has announced he is joining the venture firm NEA, Axios first reported. Gottlieb worked for the life science investing firm prior to his time heading the regulatory agency.  “I'm delighted to rejoin the venture capital firm @NEA where I worked for a decade prior to my most recent government service; and help...
By Laura Lovett 01:39 pm March 5, 2019
This morning Senseonics, an implantable glucose sensor company, announced that data from its Eversense continuous glucose monitor will be integrated into the Glooko diabetes management platform.  This means that users of the Eversense CGM and app will now be able to sync it with the Glooko online platform and app, and be able to see historical blood glucose-related data as well as get updates...
By Laura Lovett 04:23 pm February 18, 2019
This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected pens are expected to launch in early 2019, and will include Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus. As part of today’s announcement Glooko also revealed a new compatibility feature for the ...
By Jonah Comstock 03:22 pm October 23, 2018
Update: This article has been updated to clarify potentially misleading claims about Novo Nordisk being first to market. Novo Nordisk has struck a deal with Flex Digital Health, part of the IoT logistics company Flex, formerly known as Flextronics. Novo Nordisk will use Flex's BrightInsight platform, which focuses on managing connectivity and compliance for regulated digital health devices, as it...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio 08:52 am June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...
By Laura Lovett 04:13 pm June 11, 2018
Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of diabetes analytics, charts, and graphs.  “We are truly excited to supply PWDs and clinicians with the most comprehensive set of reports and analytics on diabetes data available today,” Sam Wyndbrant,...
By MobiHealthNews 04:23 pm May 16, 2018
A free tool against substance abuse. Northwell Health and the Center on Addiction have jointly launched a health care app specifically designed to guide providers when screening patients for substance use disorder. Called the SBIRT (Screening, Brief, Intervention, and Referral to Treatment) for Health Professionals app, the tool contains a standardized set of questions to ask patients when trying...
By Dave Muoio 10:53 am April 10, 2018
Digital diabetes management company Glooko announced today that Russ Johannesson will succeed Rick Altinger as the company’s new CEO. Johannesson previously served as COO of Sharecare, and as chief client officer of OptumHealth. Altinger will stay on as Glooko’s EVP of corporate development. “Digital health solutions have a proven impact for people with chronic diseases like diabetes, and Glooko...
By Dave Muoio 03:38 pm March 14, 2018
A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company. From April to October 2016, Sharp Rees-Stealy care teams provided access to Glooko's platform to 50...